A cross-country comparison of reimbursed orphan medicines in Bulgaria, Greece and Romania

Biotechnology and Biotechnological Equipment

Volumn 27, Issue 5, 2013, Pages 4186-4192

  Kamusheva, Maria ^a   Stoimenova, Assena ^a   Doneva, Miglena ^a   Zlatareva, Albena ^a   Petrova, Guenka ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Access; Bulgaria; Greece; Orphan drugs; Rare diseases; Reimbursement; Romania

Indexed keywords

ACCESS; BULGARIA; GREECE; ORPHAN DRUGS; RARE DISEASE; REIMBURSEMENT; ROMANIA;

CARDIOVASCULAR SYSTEM; DYNAMICS; LAWS AND LEGISLATION; RESPIRATORY SYSTEM;

DISEASES;

EID: 84886772543     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.5504/BBEQ.2013.0066     Document Type: Article

References (29)

1. Belgian Health Care Knowledge Centre (2009) Policies for rare diseases and orphan drugs, KCE reports 112C (Accessed: Nov. 2012)
2. Bulgarian Health Act (2004) State Gazette No 70/10, Aug. 2004.
3. Bulgarian Law on Medicinal Products in Human Medicine (2007) State Gazette, No 31/13 Apr. 2007.
4. Bulgarian National Plan for Rare Diseases (2009-2013) (genetic, birth defects and noninherited diseases), Ministry of Health, Republic of Bulgaria.
5. Commission Decision (2009) Commission Decision of 30 November 2009 establishing a European Union Committee of Experts on Rare Diseases (2009/8 72/EC), Official Journal of the European Union L, 315(2.12.2009), 18-21.
6. Commission of the European Communities (2008) Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on rare diseases: Europe's challenges, COM(2008) 679 (Accessed Nov. 2012)
7. Council Recommendation (2009) Council Recommendation of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02), Official Journal of the European Union C, 151(3.7.2009), 7-10.
8. Denis A., Mergaert L., Fostier C., Cleemput I., Simoens S. (2010) Health Policy, 97(2-3), 173-179.
9. EUCERD (2011) Overview of rare disease activiries in Europe and key developments in 2010, In: 2011 Report on the State of the Art of Rare Disease Activities in Europe of the European Union Committee of Experts on Rare Diseases (S. Aymé, C. Rodwell, Eds.) (Accessed: Nov. 2012)
10. EUCERD (2012) Overview of rare disease activities in Europe, In: 2012 Report on the State of the Art of Rare Disease Activities in Europe of the European Union Committee of Experts on Rare Diseases (S. Aymé, C. Rodwell, Eds.) (Accessed: Nov. 2012)
11. EUCERD (2012) State of the art of rare disease activities in Bulgaria, In: 2012 Report on the State of the Art of Rare Disease Activities in Europe of the European Union Committee of Experts on Rare Diseases (S. Aymé, C. Rodwell, Eds.) (Accessed: Nov. 2012)
12. EUCERD (2012) State of the art of rare disease activities in Greece, In: 2012 Report on the State of the Art of Rare Disease Activities in Europe of the European Union Committee of Experts on Rare Diseases (S. Aymé, C. Rodwell, Eds.) (Accessed: Nov. 2012)
13. EUCERD (2012) State of the art of rare disease activities in Romania, In: 2012 Report on the State of the Art of Rare Disease Activities in Europe of the European Union Committee of Experts on Rare Diseases (S. Aymé, C. Rodwell, Eds.) (Accessed: Nov. 2012)
14. European Medicines Agency (2012) Medicines for rare diseases (Accessed: Nov. 2012)
15. Greek Alliance for Rare Diseases (2013) PESPA Announcements (Accessed: Feb. 2013)
16. Iskrov G., Miteva-Katrandzhieva T., Stefanov R. (2012) Health policy, 108, 10-18.
17. Lists of Medicinal Products for Rare Diseases in Europe (2013) Orphanet Report Series, Orphan Drug Collection (Accessed: Feb. 2013)
18. Ministry of Health in Bulgaria (2011) The Positive Drug List (Accessed: Nov. 2012)
19. Ministry of Health, Greece (2012) (Accessed: Nov. 2012)
20. National Action Plan for Rare Diseases, Romania (2008-2012) (Accessed: Nov. 2012)
21. National Organisation for Medicines, Greece (2012) (Accessed: Nov. 2012)
22. Pavlovic N., Stanimirov B., Stojančević M., Paut-Kusturica M., et al. (2012) Biotechnol. Biotech. Eq., 26(5), 3236-3241.
23. Regulation (2000) Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan drugs, Official Journal of the European Communities L, 18(22.1.2000), 1-5.
24. Rinaldi A. (2005) EMBO Reports, 6(6), 507-510.
25. Romanian National Plan for Rare Diseases (2010-2014) (Accessed: Nov. 2012)
26. Simoens S. (2011) Orphanet J. Rare Dis., 6, 42.
27. Stoimenova A., Manova M., Savova A., Angelovska B., Petrova G. (2011) Biotechnol. Biotech. Eq., 25(2), 2418-2423.
28. Tejada P. (2009) Bulgaria at the forefront of rare disease policy (Accessed Nov. 2012)
29. Westermark K., Holm B.B., Söderholm M., Llinares-Garcia J., et al. (2011) Nat. Rev. Drug Discov., 10, 341-349.